Igc Pharma reports enhanced memory function with TGR-63 an Alzheimer’s mouse model
March 1, 2024
Igc Pharma Inc. has reported results of preclinical studies investigating TGR-63 as a treatment for Alzheimer’s disease, showing enhanced memory function in an Alzheimer’s mouse model, including improved memory acquisition, consolidation and retrieval.